Alembic Pharmaceuticals Limited (APLLTD) — Financial Results

· NSE Neutral
📢 Key Event
Trading window closure announced for Q1 results period
💡 Investor Takeaway
Trading restrictions will limit insider transactions until results are released.

Alembic Pharmaceuticals announced that its trading window will close on 1 July 2026 and remain closed until 48 hours after the unaudited Q1 results declaration, which will be announced at a board meeting date to be communicated later.

📄 View Original Announcement (PDF)

About Alembic Pharmaceuticals Limited (APLLTD)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,412.51 Cr P/E: 22.9 ROE: 11.8% ROCE: 11.2%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

📊 More APLLTD filings

See all APLLTD filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APLLTD — Free

Free account · 2 AI queries/day